Effects of COVID-19 on the body of a pregnant woman with preeclampsia: Birth outcomes (literature review)

Abstract

In contemporary obstetrics, increasing attention is being paid to identifying problems diagnosed during pregnancy that are believed to increase the risk of complications during pregnancy and labor. The effect of COVID-19 on the body of the pregnant woman as well as its association with preeclampsia and their combined effect on the organisms of the mother and fetus, as well as the specifics of the effect on the course and outcome of labor, have emerged as significant and well-studied problems in obstetric.

The aim of this study was to analyze the effects of COVID-19 on pregnant women with preeclampsia, including possible maternal and/or fetal complications, birth outcomes, delivery methods, and the influence of existing extragenital pathology.

The authors conducted a detailed analytical review of the scientific literature published from 2020 to 2022 on the study topic, gathering information from various sources, such as conference proceedings, technical reports, journal articles, abstracts, and papers available through databases, such as Medline, Google Scholar, and PubMed.

Based on current scientific evidence, pregnant women with COVID-19 have a high incidence of preeclampsia, preterm labor, and operative delivery. The existence of intrauterine vertical transmission has not been reliably proven. The frequency of complications in newborns corresponds with general population indicators.

Keywords

review / COVID-19 / preeclampsia / preterm labor / chorioamnionitis / cesarean section / respiratory infections / intoxication / placental detachment / endotheliitis

References

[1] Dobrokhotova YuE, Gumenyuk LN, Puchkina GA, Mikhailichenko VYu. Pregnancy complications and outcomes in women with COVID-19. Obstetrics and Gynecology. 2022;(3):32–38. (In Russ). doi: 10.18565/aig.2022.3.32-38

[2] Доброхотова Ю.Э., Гуменюк Л.Н., Пучкина Г.А., Михайличенко В.Ю. Осложнения и исходы беременности у женщин с COVID-19 // Акушерство и гинекология. 2022. № 3. С. 32–38. doi: 10.18565/aig.2022.3.32-38

[3] Kurian S, Mathews M, Reshmi VP, Divakaran B, Ajith S. Impact of diabetes on the severity of COVID-19 infection in pregnant women ― A single-center descriptive study. Diabetes Metab Syndr. 2022;16(1):102362. doi: 10.1016/j.dsx.2021.102362

[4] Kurian S., Mathews M., Reshmi V.P., Divakaran B., Ajith S. Impact of diabetes on the severity of COVID-19 infection in pregnant women ― A single-center descriptive study // Diabetes Metab Syndr. 2022. Vol. 16, N. 1. P. 102362. doi: 10.1016/j.dsx.2021.102362

[5] Arthurs AL, Jankovic-Karasoulos T, Roberts CT. COVID-19 in pregnancy: What we know from the first year of the pandemic. Biochim Biophys Acta Mol Basis Dis. 2021;1867(12):166248. doi: 10.1016/j.bbadis.2021.166248

[6] Arthurs A.L., Jankovic-Karasoulos T., Roberts C.T. COVID-19 in pregnancy: What we know from the first year of the pandemic // Biochim Biophys Acta Mol Basis Dis. 2021. Vol. 1867, N. 12. P. 166248. doi: 10.1016/j.bbadis.2021.166248

[7] Jafari M, Pormohammad A, Neshin SAS, et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis. Rev Med Virol. 2021;31(5):1–16. doi: 10.1002/rmv.2208

[8] Jafari M., Pormohammad A, Neshin SAS, et al. Clinical characteristics and outcomes of pregnant women with COVID-19 and comparison with control patients: A systematic review and meta-analysis // Rev Med Virol. 2021. Vol. 31, N. 5. P. 1–16. doi: 10.1002/rmv.2208

[9] Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145–147. doi: 10.1016/j.thromres.2020.04.013

[10] Klok F.A., Kruip M.J.H.A., van der Meer N.J.M., et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19 // Thromb res. 2020. Vol. 191. P. 145–147. doi: 10.1016/j.thromres.2020.04.013

[11] Allakhyarov DZ, Petrov YuA, Chernavsky VV. New Coronovirus Infection: Clinical and Pathogenetic Aspects of COVID-19 in Pregnant Women. Medical and pharmaceutical journal “Pulse”. 2021;23(8):57–62. (In Russ). doi: 10.26787/nydha-2686-6838-2021-23-8-57-62

[12] Аллахяров Д.З., Петров Ю.А., Чернавский В.В. Новая коронавирусная инфекция: клинические и патогенетические аспекты течения COVID-19 у беременных // Медико-фармацевтический журнал «Пульс». 2021. Т. 23, № 8. С. 57–62. doi: 10.26787/nydha-2686-6838-2021-23-8-57-62

[13] Zhukovets IV, Andrievskaya IA, Krivoshchekova NA, et al. First effects of the COVID-19 pandemic: pregnancy complications, newborn health and expected reproductive losses. Bulletin Physiology and Pathology of Respiration. 2022;(84):77–85. (In Russ). doi: 10.36604/1998-5029-2022-84-77-85

[14] Жуковец И.В., Андриевская И.А., Кривощекова Н.А., и др. Первые последствия пандемии COVID-19: осложнения беременности, здоровье новорождённых и ожидаемые репродуктивные потери // Бюллетень физиологии и патологии дыхания. 2022. № 84. С. 77–85. doi: 10.36604/1998-5029-2022-84-77-85

[15] Priputnevich TV, Gordeev AB, Lyubasovskaya LA, Shabanova NE. The novel coronavirus SARS-COV-2 and pregnancy: literature review. Obstetrics and Gynecology. 2020;(5):6–12. (In Russ). doi: 10.18565/aig.2020.5.6-12

[16] Припутневич Т.В., Гордеев А.Б., Любасовская Л.А., Шабанова Н.Е. Новый коронавирус SARS-COV-2 и беременность: обзор литературы // Акушерство и гинекология. 2020. № 5. С. 6–12. doi: 10.18565/aig.2020.5.6-12

[17] Gareyeva AI, Mozgovaya EV, Belopolskaya MA, Kovalchuk AS, Kucheryavenko AN. Experience in managing severe and extremely severe COVID-19 in pregnant women. Journal of Obstetrics and Women’s Diseases. 2022;71(1):11–22. (In Russ). doi: 10.17816/JOWD72169

[18] Гареева А.И., Мозговая Е.В., Белопольская М.А., Ковальчук А.С., Кучерявенко А.Н. Опыт ведения беременных с тяжёлой и крайне тяжёлой формами COVID-19 // Журнал акушерства и женских болезней. 2022. Т. 71, № 1. С. 11–22. doi: 10.17816/JOWD72169

[19] Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417−1418. doi: 10.1016/S0140-6736(20)30937-5

[20] Varga Z., Flammer A.J., Steiger P., et al. Endothelial cell infection and endotheliitis in COVID-19 // Lancet. 2020. Vol. 395, N. 10234. P. 1417−1418. doi: 10.1016/S0140-6736(20)30937-5

[21] Makhmudova SE. The features of the severe pre-eclampsia during the COVID-19 pandemic. Journal of cardiorespiratory research. 2020;(Sp. Issue 1):33–36. (In Russ). doi: 10.26739/2181-0974-2020-SI-1-7

[22] Махмудова С. Особенности течения тяжёлой преэклампсии в условиях пандемии COVID-19 // Журнал кардиореспираторных исследований. 2022. Спец. выпуск 1. С. 33–36. doi: 10.26739.2181-0974-2020-SI-1-7

[23] Kuneshko NF, Gavrikova DI, Golomazova VA, Kim VV. COVID-19 impact on development, course and outcome of pregnancy. International Research Journal. 2022;(5, p. 1):146–156. (In Russ). doi: 10.23670/IRJ.2022.119.5.065

[24] Кунешко Н.Ф., Гаврикова Д.И., Голомазова В.А., Ким В.В. Влияние перенесённой новой коронавирусной инфекции на развитие, течение и исход беременности // Международный научно-исследовательский журнал. 2022. № 5, ч. 1. С. 146–156. doi: 10.23670/IRJ.2022.119.5.065

[25] Shchegolev AI, Tumanova UN, Serov VN. Placental lesions in pregnant women with SARS-CoV-2 infection. Obstetrics and Gynecology. 2020;(12):44–52. (In Russ). doi: 10.18565/aig.2020.12.44-52

[26] Щеголев А.И., Туманова У.Н., Серов В.Н. Поражения плаценты у беременных с SARS-CoV-2-инфекцией // Акушерство и гинекология. 2020. № 12. C. 44–52. doi: 10.18565/aig.2020.12.44-52

[27] Shanes ED, Mithal LB, Otero S, et al. Placental Pathology in COVID-19. Am J Clin Pathol. 2020;154(1):23–32. doi: 10.1093/ajcp/aqaa089

[28] Shanes E.D., Mithal L.B., Otero S., et al. Placental Pathology in COVID-19 // Am J Clin Pathol. 2020. Vol. 154, N. 1. P. 23–32. doi: 10.1093/ajcp/aqaa089

[29] Verma S, Bradshaw C, Auyeung NSF, et al. Outcomes of Maternal-Newborn Dyads After Maternal SARS-CoV-2. Pediatrics. 2020;146(4):e2020005637. doi: 10.1542/peds.2020-005637

[30] Verma S., Bradshaw C., Auyeung N.S.F., et al. Outcomes of Maternal-Newborn Dyads After Maternal SARS-CoV-2 // Pediatrics. 2020. Vol. 146, N. 4. P. e2020005637. doi: 10.1542/peds.2020-005637

[31] Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020;5(6):529–530. doi: 10.1016/S2468-1253(20)30084-4

[32] Bangash M.N., Patel J., Parekh D. COVID-19 and the liver: little cause for concern // Lancet Gastroenterol Hepatol. 2020. Vol. 5, N. 6. P. 529–530. doi: 10.1016/S2468-1253(20)30084-4

[33] Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: Maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020;144(7):799–805. doi: 10.5858/arpa.2020-0901-SA

[34] Schwartz D.A. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: Maternal coronavirus infections and pregnancy outcomes // Arch Pathol Lab Med. 2020. Vol. 144, N. 7. P. 799–805. doi: 10.5858/arpa.2020-0901-SA

[35] Naves do Amaral W, de Moraes CL. Maternal Coronavirus Infections and Neonates Born to Mothers with SARS-CoV-2: A Systematic Review. Healthcare (Basel). 2020;8(4):511. doi: 10.3390/healthcare8040511

[36] Naves do Amaral W., de Moraes C.L. Maternal Coronavirus Infections and Neonates Born to Mothers with SARS-CoV-2: A Systematic Review // Healthcare (Basel). 2020. Vol. 8, N. 4. P. 511. doi: 10.3390/healthcare8040511

[37] Zamaniyan M, Ebadi A, Aghajanpoor S, et al. Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID-19 infection. Prenat Diagn. 2020;40(13):1759–1761. doi: 10.1002/pd.5713

[38] Zamaniyan M., Ebadi A., Aghajanpoor S., et al. Preterm delivery, maternal death, and vertical transmission in a pregnant woman with COVID-19 infection // Prenat Diagn. 2020. Vol. 40, N. 13. P. 1759–1761. doi: 10.1002/pd.5713

[39] Mirbeyk M, Saghazadeh A, Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates. Archives Gynecology and Obstetrics. 2021;304(1):5–38. doi: 10.1007/s00404-021-06049-z

[40] Mirbeyk M., Saghazadeh A., Rezaei N. A systematic review of pregnant women with COVID-19 and their neonates // Archives Gynecology and Obstetrics. 2021. Vol. 304, N. 1. P. 5–38. doi: 10.1007/s00404-021-06049-z

[41] Alzamora MC, Paredes T, Caceres D, et al. Severe COVID-19 during Pregnancy and Possible Vertical Transmission. Am J Perinatol. 2020;37(8):861–865. doi: 10.1055/s-0040-1710050

[42] Alzamora M.C., Paredes T., Caceres D., et al. Severe COVID19 during pregnancy and possible vertical transmission // Am J Perinatol. 2020. Vol. 37, N. 8. P. 861–865. doi: 10.1055/s-0040-1710050

RIGHTS & PERMISSIONS

Eco-Vector